Cambodia Pharmaceuticals & Healthcare Q3 2018
Cambodia’s pharmaceutical market will post high growth rates over the next 10 years, creating improved opportunitiesfor drugmakers operating in the country. However, given low affordability levels and the underdeveloped healthcare system, low-cost generic medicines will continue to dominate the market. Moreover, the small domestic market size, combined withcumbersome bureaucracy and low patent protection, will continue to impose restrictions on multinational pharmaceutical firms'revenue growth prospects. We highlight, however, that the rising burden of chronic diseases such as cancer and lifestyle-relatedchronic conditions will translate into rising demand for treatment over a multi-year timeframe.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook